Corporate Announcement
Security Code : 532331    Company : AJANTPHARM    
 
Ajanta Pharma Announces the Launch of Montelukast Sodium Oral GranulesDownload PDF
  Exchange Disseminated Time     16/11/2015 17:43:02
Ajanta Pharma Ltd has informed BSE that the Company’s subsidiary viz., Ajanta Pharma USA Inc. has launched Montelukast sodium oral granules in US market. In this regard, the Company has issued a Press Release dated November 16, 2015 titled "Ajanta Pharma Announces the Launch of Montelukast Sodium Oral Granules".
 

Disclaimer

Back To Announcements